+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pediatric Vaccines Market by Vaccine Type, by Technology, by Indication, by Distribution Channel, and by Region

  • PDF Icon

    Report

  • 200 Pages
  • October 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 6008304
The global pediatric vaccines market accounted for USD 54.17 billion in 2023 and is expected to reach at USD 156.57 billion by 2034 with a CAGR of 10.13% during the forecast period 2024-2034. The market will grow as a result of factors such as expanding immunization programs, increasing government funding and support, growing emphasis on preventive healthcare, rising disease prevalence, and increased awareness and education.

The significance of vaccination in reducing childhood illnesses has come to the forefront of public consciousness. Parents' education regarding the advantages of pediatric vaccinations has been greatly aided by government programs, healthcare associations, and non-profit campaigns. As a result, the industry is expanding as more parents choose to vaccinate their kids. For instance, in February 2024, GSK and Sanofi Pasteur announced a strategic partnership to develop and market next-generation combination vaccines for kids, which will include a five-in-one vaccine that targets HIV, polio, tetanus, pertussis, and diphtheria (Hib).

By vaccine type, the multivalent vaccines segment accounted for the highest revenue-grossing segment in the global pediatric vaccines market in 2023 and is predicted to grow at the fastest CAGR during the forecast period owing to the increased convenience of administering multiple vaccinations in a single dose, reducing the need for multiple clinic visits and improving compliance rates among parents and healthcare providers. For instance, Pfizer's novel respiratory syncytial virus (RSV) vaccine candidate for newborns wins FDA approval in April 2024, potentially providing protection against a major cause of pediatric hospitalizations.

By technology, the inactivated vaccines segment accounted for the highest revenue-grossing segment in the global pediatric vaccines market in 2023 owing to the high demand for vaccines with proven safety records, especially among parents and healthcare providers concerned about adverse reactions associated with live attenuated vaccines. For instance, Sanofi reports encouraging Phase 3 trial findings for their experimental dengue vaccine candidate in March 2024, which might represent a major advancement in public health in areas with high dengue incidence. Additionally, the conjugate vaccines segment is predicted to grow at the fastest CAGR during the forecast period owing to the increased efficacy in targeting bacterial diseases by enhancing the immune response, especially in infants and young children, leading to greater adoption and demand in the market.

By indication, the mumps and rubella segment accounted for the highest revenue-grossing segment in the global pediatric vaccines market in 2023 owing to the rising incidence of mumps and rubella outbreaks worldwide, driving demand for vaccinations to prevent these diseases and achieve herd immunity. For instance, in January 2024, Merck & Co. acquires a smaller company that specializes in rotavirus vaccines to broaden its line of pediatric vaccinations and increase its market share in developing nations. Additionally, the pneumococcal disease segment is predicted to grow at the fastest CAGR during the forecast period owing to the increased awareness about the severity of pneumococcal infections and the introduction of newer vaccines targeting a broader range of pneumococcal strains, especially in emerging economies with expanding immunization programs.

By end-user, the institutional health centers segment accounted for the highest revenue-grossing segment in the global pediatric vaccines market in 2023 owing to the increased access to vaccines through government-funded immunization programs and partnerships with healthcare providers, ensuring widespread coverage and higher vaccination rates among children. For instance, in January 2024, Merck & Co. acquires a smaller company that specializes in rotavirus vaccines to broaden its line of pediatric vaccinations and increase its market share in developing nations. Additionally, the retail pharmacies segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing convenience and accessibility for parents to obtain pediatric vaccines, coupled with the expansion of vaccination services and immunization awareness campaigns in retail pharmacy settings.

North American region is anticipated to have the highest revenue share during the forecast period owing to the high vaccination rates, robust healthcare infrastructure, strong government support for immunization programs, and a well-established market for pediatric vaccines. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly growing population, increasing investments in healthcare infrastructure, rising disposable income levels, expanding immunization programs, and a growing focus on preventive healthcare measures. For instance, in October 2023, AstraZeneca and the Bill & Melinda Gates Foundation collaborated to create and supply a novel pneumococcal conjugate vaccination for underdeveloped nations.

This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Vaccine Type, Technology, Indication, and Distribution Channel
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players
  • 20% Free Customization Available to Meet Your Exact Requirement

Segmentation: Pediatric Vaccines Market Report 2023 - 2034

Pediatric Vaccines Market Analysis & Forecast by Vaccine Type 2023 - 2034 (Revenue USD Bn)

  • Monovalent
  • Multivalent

Pediatric Vaccines Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)

  • Live Attenuated
  • Inactivated
  • Toxoid
  • Conjugate
  • Other Technologies

Pediatric Vaccines Market Analysis & Forecast by Indication 2023 - 2034 (Revenue USD Bn)

  • Varicella
  • Human Papilloma Virus
  • Measles
  • Mumps and Rubella
  • Meningococcal Disease
  • Pneumococcal Disease
  • Polio
  • Rotavirus
  • Diphtheria
  • Pertussis and Tetanus
  • Influenza
  • Other Indications

Pediatric Vaccines Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Institutional Health Centres

Pediatric Vaccines Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Pediatric Vaccines Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Pediatric Vaccines Market: Vaccine Type Estimates & Trend Analysis
7.1. Vaccine Type Segment Opportunity Analysis
7.2. Monovalent
7.2.1. Monovalent Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Multivalent
7.3.1. Multivalent Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Pediatric Vaccines Market: Technology Estimates & Trend Analysis
8.1. Technology Segment Opportunity Analysis
8.2. Live Attenuated
8.2.1. Live Attenuated Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Inactivated
8.3.1. Inactivated Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Toxoid
8.4.1. Toxoid Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Conjugate
8.5.1. Conjugate Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.6. Other Technologies
8.6.1. Other Technologies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Pediatric Vaccines Market: Indication Estimates & Trend Analysis
9.1. Indication Segment Opportunity Analysis
9.2. Varicella
9.2.1. Varicella Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Human Papilloma Virus
9.3.1. Human Papilloma Virus Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Measles
9.4.1. Measles Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.5. Mumps and Rubella
9.5.1. Mumps and Rubella Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.6. Meningococcal Disease
9.6.1. Meningococcal Disease Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.7. Pneumococcal Disease
9.7.1. Pneumococcal Disease Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.8. Polio
9.8.1. Polio Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.9. Rotavirus
9.9.1. Rotavirus Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.10. Diphtheria
9.10.1. Diphtheria Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.11. Pertussis and Tetanus
9.11.1. Pertussis and Tetanus Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.12. Influenza
9.12.1. Influenza Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.13. Other Indications
9.13.1. Other Indications Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Pediatric Vaccines Market: Distribution Channel Estimates & Trend Analysis
10.1. Distribution Channel Segment Opportunity Analysis
10.2. Hospital Pharmacies
10.2.1. Hospital Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.3. Retail Pharmacies
10.3.1. Retail Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.4. Institutional Health Centres
10.4.1. Institutional Health Centres Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11. Regional Market Analysis
11.1. Regional Market Opportunity Analysis
12. North America Pediatric Vaccines Market
12.1. North America Pediatric Vaccines Market
12.1.1. North America Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. North America Pediatric Vaccines Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. North America Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
12.1.4. North America Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
12.1.5. North America Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.1.6. North America Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.2. U.S. Global Pediatric Vaccines Market
12.2.1. U.S. Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. U.S. Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
12.2.3. U.S. Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
12.2.4. U.S. Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.2.5. U.S. Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.3. Canada Global Pediatric Vaccines Market
12.3.1. Canada Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. Canada Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
12.3.3. Canada Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
12.3.4. Canada Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.3.5. Canada Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13. Europe Global Pediatric Vaccines Market
13.1. Europe Global Pediatric Vaccines Market
13.1.1. Europe Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Europe Pediatric Vaccines Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Europe Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
13.1.4. Europe Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.1.5. Europe Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.1.6. Europe Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.2. Germany Global Pediatric Vaccines Market
13.2.1. Germany Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Germany Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
13.2.3. Germany Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.2.4. Germany Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.2.5. Germany Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.3. UK Global Pediatric Vaccines Market
13.3.1. UK Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. UK Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
13.3.3. UK Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.3.4. UK Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.3.5. UK Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.4. France Global Pediatric Vaccines Market
13.4.1. France Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. France Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
13.4.3. France Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.4.4. France Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.4.5. France Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.5. Spain Global Pediatric Vaccines Market
13.5.1. Spain Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. Spain Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
13.5.3. Spain Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.5.4. Spain Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.5.5. Spain Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.6. Italy Global Pediatric Vaccines Market
13.6.1. Italy Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Italy Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
13.6.3. Italy Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.6.4. Italy Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.6.5. Italy Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.7. Rest of Europe Global Pediatric Vaccines Market
13.7.1. Rest of Europe Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Europe Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Europe Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Europe Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.7.5. Rest of Europe Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14. Asia Pacific Global Pediatric Vaccines Market
14.1. Asia Pacific Global Pediatric Vaccines Market
14.1.1. Asia Pacific Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Asia Pacific Pediatric Vaccines Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Asia Pacific Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
14.1.4. Asia Pacific Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
14.1.5. Asia Pacific Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.1.6. Asia Pacific Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2. Japan Global Pediatric Vaccines Market
14.2.1. Japan Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Japan Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
14.2.3. Japan Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
14.2.4. Japan Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.2.5. Japan Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3. China Global Pediatric Vaccines Market
14.3.1. China Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. China Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
14.3.3. China Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
14.3.4. China Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.3.5. China Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.4. India Global Pediatric Vaccines Market
14.4.1. India Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. India Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
14.4.3. India Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
14.4.4. India Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.4.5. India Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.5. South Korea Global Pediatric Vaccines Market
14.5.1. South Korea Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. South Korea Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
14.5.3. South Korea Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
14.5.4. South Korea Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.5.5. South Korea Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.6. Australia Global Pediatric Vaccines Market
14.6.1. Australia Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.6.2. Australia Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
14.6.3. Australia Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
14.6.4. Australia Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.6.5. Australia Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.7. Rest of Asia Pacific Global Pediatric Vaccines Market
14.7.1. Rest of Asia Pacific Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.7.2. Rest of Asia Pacific Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
14.7.3. Rest of Asia Pacific Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
14.7.4. Rest of Asia Pacific Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.7.5. Rest of Asia Pacific Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15. Latin America Global Pediatric Vaccines Market
15.1. Latin America Global Pediatric Vaccines Market
15.1.1. Latin America Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. Latin America Pediatric Vaccines Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. Latin America Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
15.1.4. Latin America Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
15.1.5. Latin America Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.1.6. Latin America Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.2. Brazil Global Pediatric Vaccines Market
15.2.1. Brazil Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. Brazil Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
15.2.3. Brazil Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
15.2.4. Brazil Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.2.5. Brazil Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.3. Mexico Global Pediatric Vaccines Market
15.3.1. Mexico Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. Mexico Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
15.3.3. Mexico Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
15.3.4. Mexico Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.3.5. Mexico Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.4. Argentina Global Pediatric Vaccines Market
15.4.1. Argentina Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Argentina Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
15.4.3. Argentina Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
15.4.4. Argentina Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.4.5. Argentina Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.5. Rest of Latin America Global Pediatric Vaccines Market
15.5.1. Rest of Latin America Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.5.2. Rest of Latin America Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
15.5.3. Rest of Latin America Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
15.5.4. Rest of Latin America Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.5.5. Rest of Latin America Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16. MEA Global Pediatric Vaccines Market
16.1. MEA Global Pediatric Vaccines Market
16.1.1. MEA Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.1.2. MEA Pediatric Vaccines Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
16.1.3. MEA Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
16.1.4. MEA Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
16.1.5. MEA Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
16.1.6. MEA Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.2. GCC Global Pediatric Vaccines Market
16.2.1. GCC Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.2.2. GCC Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
16.2.3. GCC Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
16.2.4. GCC Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
16.2.5. GCC Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.3. South Africa Global Pediatric Vaccines Market
16.3.1. South Africa Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.3.2. South Africa Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
16.3.3. South Africa Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
16.3.4. South Africa Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
16.3.5. South Africa Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.4. Rest of MEA Global Pediatric Vaccines Market
16.4.1. Rest of MEA Pediatric Vaccines Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.4.2. Rest of MEA Pediatric Vaccines Market Size and Forecast, By Vaccine Type, 2023-2034 (Revenue USD Bn)
16.4.3. Rest of MEA Pediatric Vaccines Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
16.4.4. Rest of MEA Pediatric Vaccines Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
16.4.5. Rest of MEA Pediatric Vaccines Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
17. Competitor Analysis
17.1. Company Market Share Analysis, 2023
17.2. Major Recent Developments
18. Company Profiles
18.1. GlaxoSmithKline plc
18.2. Pfizer Inc.
18.3. Sanofi
18.4. Merck & Co., Inc.
18.5. Johnson & Johnson
18.6. Novartis International AG (now part of GlaxoSmithKline)
18.7. AstraZeneca plc
18.8. CSL Limited
18.9. Emergent BioSolutions Inc.
18.10. Sinovac Biotech Ltd.
18.11. Bharat Biotech
18.12. Serum Institute of India Pvt. Ltd.
18.13. Daiichi Sankyo Company, Limited
18.14. Bavarian Nordic A/S
18.15. Takeda Pharmaceutical Company Limited
19. Conclusion20. Recommendations

Companies Mentioned

  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sanofi
  • Merck & Co. Inc.
  • Johnson & Johnson
  • Novartis International AG
  • AstraZeneca plc
  • CSL Limited
  • Emergent BioSolutions Inc.
  • Sinovac Biotech Ltd.
  • Bharat Biotech
  • Serum Institute of India Pvt. Ltd.
  • Daiichi Sankyo Company
  • Limited
  • Bavarian Nordic A/S
  • Takeda Pharmaceutical Company Limited.

Table Information